Signature Estate & Investment Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Signature Estate & Investment Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,388	Closed	-$179K	–	128
2015 Q3	$179K	Hold	2,388	–	–	0.04%	90
2015 Q2	$180K	Sell	2,388 -2,000	-46%	-$107K	0.04%	76
2015 Q1	$220K	Hold	4,388	–	–	0.06%	71
2014 Q4	$152K	Hold	4,388	–	–	0.05%	69
2014 Q3	$144K	Buy	+4,388	New	+$155K	0.05%	62
2013 Q4	–	Sell	-4,388	Closed	-$200K	–	62
2013 Q3	$200K	Buy	+4,388	New	+$131K	0.12%	51

Signature Estate & Investment Advisors's KYTH Position: Q4 2015 in Review

Signature Estate & Investment Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 2,388 shares — an estimated $179K sold.

Signature Estate & Investment Advisors first reported a position in KYTH in Q3 2013 and held it in 6 quarters. The position peaked at $220K in Q1 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Signature Estate & Investment Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Signature Estate & Investment Advisors sold 2,388 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $179K.
Signature Estate & Investment Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 6 quarters.
Signature Estate & Investment Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $220K in Q1 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Signature Estate & Investment Advisors's 13F filing for Q4 2015, filed 10 Feb 2016.